Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tripstar: a comprehensive patient-based approach to compare triptans.

Michel D Ferrari1

  • 1Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Headache
|April 23, 2002
PubMed
Summary

Newer triptans like almotriptan, rizatriptan, and eletriptan show superiority over sumatriptan for migraine relief. A novel scoring system, Tripstar, helps compare these migraine treatments based on various factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression.

Cephalalgia : an international journal of headache·2026
Same author

Tsunamis hiding in plain sight: spreading depression in clinical neurology.

Nature reviews. Neurology·2026
Same author

Risk and reward seeking behaviour in episodic cluster headache - a psychometric and behavioural study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Correlation of Amine Concentrations in Blood and Cerebrospinal Fluid in Healthy Volunteers and Migraineurs.

International journal of molecular sciences·2025
Same author

Greater occipital nerve injection with methylprednisolone as transitional therapy in episodic cluster headache: Results from an RCT.

Cephalalgia : an international journal of headache·2025
Same author

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache.

Headache·2025

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Trials

Background:

  • Several second-generation triptans offer distinct pharmacological profiles compared to sumatriptan.
  • The increasing number of therapeutic options necessitates clear differentiation among migraine treatments for clinicians.

Purpose of the Study:

  • To compare the efficacy and tolerability of various oral triptans for migraine treatment.
  • To introduce and evaluate a flexible scoring system (Tripstar) for assessing migraine drug acceptability.

Main Methods:

  • A meta-analysis of 53 double-blind, randomized trials involving over 24,000 patients receiving oral triptans.
  • Development and informal testing of the Tripstar scoring system, integrating meta-analysis data with weighted treatment criteria.

Related Experiment Videos

Main Results:

  • Almotriptan 12.5 mg, rizatriptan 10 mg, and eletriptan 80 mg demonstrated superiority over sumatriptan 100 mg in individual treatment attributes.
  • The Tripstar model initially identified sumatriptan as most similar to the ideal, influenced by its widespread clinical exposure.
  • Excluding exposure, almotriptan 12.5 mg emerged as most similar to the ideal due to its favorable tolerability profile.

Conclusions:

  • Second-generation triptans offer improved therapeutic options for migraine management.
  • The Tripstar model provides a framework for a more comprehensive comparison of migraine treatments beyond individual endpoints.
  • Almotriptan shows promise as a highly tolerable and effective migraine treatment.